The stock of Cypress Semiconductor Corporation (NASDAQ ... Menta Capital …
Nektar’s PEGylation technology has facilitated the development of 10 approved products in the U.S. and the EU, through partnerships with healthcare …
Shares of Amgen (NASDAQ:AMGN) opened today below their pivot of $163.85 and have ... price of $163.53 and an average consensus analyst price target of $185.86. The stock should find initial support at its 200-day moving average (MA) of …
Amgen Inc. (NASDAQ:AMGN) stock still has plenty of life, despite the market’s lukewarm take on the biotech giant in 2015. Although the market reacted negatively to AMGN’s prospects on its product line and future earnings, a second …
And what better biotech stock is there than AMGN stock? Amgen, Inc. (NASDAQ:AMGN) is one of the largest biotechnology companies in the world, …
ValuEngine downgraded shares of Amgen Inc. (NASDAQ:AMGN) from a buy rating to a hold rating in a research report released on Friday, June 2nd. AMGN has been the topic of a number of other reports. Argus set a $195.00 price target …
BNS14d
The biotech sector has had an interesting 12-month period: the rhetoric of U.S. elections and now into the Trump era. So considering the barrage of headlines, it’s no surprise to see that Amgen, Inc. (NASDAQ:AMGN) stock has been …
MSN1mon
Amgen stock is in the red -- down 2% at $153.44 -- after the company said it no longer expects its experimental osteoporosis drug to win Food and Drug Administration (FDA) approval. Adding insult to injury, Morgan Stanley cut its …
Amgen, Inc. (NASDAQ:AMGN)‘s stock had its “hold” rating restated by Jefferies Group LLC in a research note issued to investors on Monday. They currently have a $180.00 price objective on the medical research company’s stock. Jefferies …
Breeze1mon
Investors in Amgen Inc (NASD: AMGN) saw new options become available this week, for the March 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMGN options chain for the new March …